These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27313108)

  • 21. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AUTHOR'S CORRECTION: Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Bedenić B
    Med Glas (Zenica); 2017 Aug; 14(2):269. PubMed ID: 29148521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.
    Tenover FC; Emery SL; Spiegel CA; Bradford PA; Eells S; Endimiani A; Bonomo RA; McGowan JE
    J Clin Microbiol; 2009 Feb; 47(2):294-9. PubMed ID: 19036936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation of the frequency and distribution of beta-lactamase genes in the clinical isolates of Acinetobacter baumannii collected from different regions of Turkey: a multicenter study].
    Beriş FŞ; Budak EE; Gülek D; Uzun A; Çizmeci Z; Mengeloğlu FZ; Direkel Ş; Çetinkol Y; Ay Altıntop Y; Iraz M; Dal T; Say Coşkun SU; Balcı PÖ; Kayman T; Çalışkan A; Yazıcı Y; Tosun İ; Ertürk A; Çopur Çiçek A
    Mikrobiyol Bul; 2016 Oct; 50(4):511-521. PubMed ID: 28124956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae.
    Al-Agamy MH
    Pak J Pharm Sci; 2013 Mar; 26(2):291-8. PubMed ID: 23455199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping.
    Hassan MI; Alkharsah KR; Alzahrani AJ; Obeid OE; Khamis AH; Diab A
    J Infect Dev Ctries; 2013 Aug; 7(8):618-29. PubMed ID: 23949298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characteristics and antibiotic resistance of Acinetobacter baumanniibeta-lactamase-producing isolates, a predominance of intrinsic blaOXA-51, and detection of TEM and CTX-M genes.
    Ibrahimagić A; Kamberović F; Uzunović S; Bedenić B; Idrizović E
    Turk J Med Sci; 2017 Apr; 47(2):715-720. PubMed ID: 28425271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
    Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
    Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
    Karkaba A; Grinberg A; Benschop J; Pleydell E
    N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.
    Shaaban M; Elshaer SL; Abd El-Rahman OA
    BMC Microbiol; 2022 Oct; 22(1):247. PubMed ID: 36221063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
    Bakthavatchalu S; Shakthivel U; Mishra T
    Pan Afr Med J; 2013; 14():28. PubMed ID: 23504148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of extended-spectrum beta-lactamases and its correlation with clinical laboratory standards institute interpretive criteria for disk diffusion susceptibility testing in enterobacteriaceae isolates in Thaialnd.
    Tangkoskul T; Tiengrim S; Onsomang S; Pati N; Aswapokee N; Thamlikitkul V; Chayakulkeeree M
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1461-9. PubMed ID: 23413710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.